GLTPD2

RNA expression — cross-omics
Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, GLTPD2 RNA expression is significantly associated with the protein abundance of many other proteins, with 7,516 significant associations in total. CCRCC shows the largest number of these associations.

The most reproducible GLTPD2-associated proteins across cancer lineages are CALU, VPS37B, and ZMYND11_S403. Each is linked with GLTPD2 in more than 3 cancer types. Because this analysis shows association rather than direction, both GLTPD2-to-partner and partner-to-GLTPD2 results are reported.

Each partner links to its own Q-omics profile. The scatter plot shows the strongest example, GLTPD2 versus CALU in GBM, with a Pearson correlation of -0.40.

RNA expression associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (GLTPD2→partner) and Y-score (partner→GLTPD2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMCALU →-0.415-0.351<.001<.00134
PDACVPS37B →-0.203-0.271.001.00233
GBMZMYND11_S403 →+0.509+0.405<.001.00133
OVYWHAE →+0.358+0.578.001.00133
BRCAOSCP1 →+0.440+0.524<.001<.00133
LUADMET →-0.506-0.658.005<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest of 7,516 associations by consensus.

GLTPD2 vs CALU — GBM

Per-sample scatter of GLTPD2 vs CALU in GBM (Pearson r = -0.40).

Explore this scatter interactively →

Exploration